Ahead of the Tape: Merck and Pfizer are cash machines in a frothy pharmaceutical sector.
The official first-quarter GDP growth of 7% is overstated, experts agree, but pinning down the real number is a head-scratcher.
Apple is pulling off a feat rarely seen in any industry, much less the cutthroat world of consumer electronics: gaining market share while also commanding higher prices.
Federal regulators may reject Dish Network’s attempt to benefit from billions of dollars in small-business discounts in a record auction of wireless licenses.
Institutional Shareholder Services said DuPont shareholders should elect Nelson Peltz and John Myers, two of the four nominees Mr. Peltz’s Trian Fund Management to the board.
Years of falling sales in the U.S. and a murky strategy cast doubt on the likelihood that Avon’s efforts are enough to revive the 129-year-old beauty empire.
Harvey R. Miller is credited with developing the modern practice of bankruptcy law while guiding Texaco, Lehman, GM and others through bankruptcy and restructuring.
The Nikkei hitting a 15-year high isn’t a reason not to buy into the rally. But it is time for Japan investors to become more discerning?
Deutsche Bank aims to close gap between itself and rivals in terms of profitability and capital adequacy.